Tuesday's session: top gainers and losers
By Mill Chart
Last update: Apr 16, 2024
Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| NCNA | 2.0K% | NUCANA PLC-ADR's (NASDAQ:NCNA) stock price displayed strong growth, advancing 2.0K% and reaching $3.89 during Tuesday's session. Earlier today the company had a press release: NuCana Announces Completion of ADS Ratio Change. |
| WISA | 218.0% | Investors celebrated as WISA TECHNOLOGIES INC (NASDAQ:WISA) experienced a 218.0% rise in its shares, closing at $5.57 during Tuesday's session. Earlier today the company had a press release: WiSA Inks Fourth HDTV/PTV License with Multi-billion Dollar Revenue Company, Signaling Rapid Adoption for its WiSA E Immersive Audio Technology. |
| JAGX | 50.67% | Investors witnessed a remarkable 50.67% rise in JAGUAR HEALTH INC's (NASDAQ:JAGX) shares, which climbed to $0.18 during Tuesday's session. In the last month the share price increased with 69.71%. |
| SXTC | 45.9% | CHINA SXT PHARMACEUTICALS IN (NASDAQ:SXTC) experienced a significant 45.9% increase, reaching $1.71 during Tuesday's session. In the last month the stock lost 32.76%. |
| BTTR | 37.45% | Positive market sentiment drove BETTER CHOICE CO INC's (NYSEARCA:BTTR) stock price up by 37.45% to $7.01 during Tuesday's session. In the last 3 months the share price dropped with 54.19%. |
| PALI | 32.69% | PALISADE BIO INC (NASDAQ:PALI) experienced a significant 32.69% increase, reaching $5.52 during Tuesday's session. The stock is trading 23.07% lower than a month ago. |
| BSGM | 31.82% | BIOSIG TECHNOLOGIES INC (NASDAQ:BSGM) rose 31.82% to $1.45 during Tuesday's after hours session. In the last month the stock gained 107.0%. |
| VERO | 31.15% | VENUS CONCEPT INC's (NASDAQ:VERO) shares rose 31.15% to $0.8 during Tuesday's session. The stock is trading 54.48% lower than 3 months ago. |
| KA | 30.88% | KINETA INC (NASDAQ:KA) experienced a significant 30.88% increase, reaching $0.45 during Tuesday's session. In the last month the share price dropped with 37.61%. |
| BACK | 27.76% | IMAC HOLDINGS INC (NASDAQ:BACK) witnessed a notable 27.76% uptick in its shares, reaching $4.28 during Tuesday's session. In the last month the stock gained 160.0%. |
For the full top gainers list go to our top gainers page.
Top losers
| Ticker | Change | Comment |
|---|---|---|
| BNED | -67.14% | BARNES & NOBLE EDUCATION INC's (NYSE:BNED) stock price decreased by 67.14% to $0.23. Earlier today the company had a press release: Barnes & Noble Education Announces Milestone Transactions to Significantly Strengthen Balance Sheet and Advance Industry Leading Services for Institutions and Students. |
| CLDI | -58.35% | Investors witnessed a 58.35% decrease in CALIDI BIOTHERAPEUTICS INC's (NYSEARCA:CLDI) stock price, which closed at $0.25 during Tuesday's session. Earlier today the company had a press release: Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering. |
| PACB | -44.88% | There was a downturn in PACIFIC BIOSCIENCES OF CALIF's (NASDAQ:PACB) shares, as they experienced a 44.88% decline, closing at $1.56 during Tuesday's session. Shareholders saw the stock price going 25.2% lower in the past month. |
| FFIEW | -33.33% | FARADAY FUTURE -CW27's (NASDAQ:FFIEW) stock price is declining with 33.33% to a price of $0.01. The stock is trading 44.55% higher than a month ago. |
| KAVL | -29.68% | KAIVAL BRANDS INNOVATIONS GR's (NASDAQ:KAVL) stock price is declining with 29.68% to a price of $4.43. Shareholders saw the stock price going 207.0% higher in the past month. |
| OMQS | -25.71% | OMNIQ CORP's (NASDAQ:OMQS) stock price encountered a 25.71% decline, reaching $0.52 during Tuesday's session. Shareholders saw the stock price going 84.77% lower is the past year. |
| NXL | -24.75% | NEXALIN TECHNOLOGY INC's (NASDAQ:NXL) stock price faced a 24.75% decline, reaching $1.49 during Tuesday's session. Shareholders saw the stock price going 320.0% higher in the past month. |
| CZOO | -21.62% | The market experienced a downward movement in CAZOO GROUP LTD's (NYSE:CZOO) stock price, closing at $5.8 with a 21.62% decrease during Tuesday's session. The stock is trading 249.0% higher than a month ago. |
| CNEY | -21.51% | CN ENERGY GROUP INC-A's (NASDAQ:CNEY) shares fell 21.51% to $0.73. In the last 3 months the stock lost 41.88%. |
| EGIO | -19.82% | EDGIO INC's (NASDAQ:EGIO) stock price faced a 19.82% decline, reaching $16.55 during Tuesday's session. In the last month the share price increased with 168.0%. |
To see the full list of top losers you can use our top losers page.
KINETA INC
NASDAQ:KA (5/6/2024, 7:10:32 PM)
0.582
-0.01 (-1.34%)
KA News
18 days ago - ChartmillWhat's going on in today's pre-market sessionFriday's pre-market session: top gainers and losers
20 days ago - ChartmillStay updated with the stocks that are on the move in today's after-hours session.Tuesday's after hours session: top gainers and losers
20 days ago - ChartmillTuesday's session: top gainers and losersWondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
20 days ago - ChartmillHere are the top movers in Tuesday's session, showcasing the stocks with significant price changes.Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts
2 months ago - BusinessInsiderKA Stock Earnings: Kineta Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kineta (NASDAQ:KA) just reported results for the fourth quarter of 2023.Kineta ...
2 months ago - InvestorPlaceKA Stock Earnings: Kineta Beats EPS for Q4 2023KA stock results show that Kineta beat analyst estimates for earnings per share the fourth quarter of 2023.
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts in the VISTA-101 trial No...
